Dezheng Huo to Cyclin-Dependent Kinase Inhibitor p16
This is a "connection" page, showing publications Dezheng Huo has written about Cyclin-Dependent Kinase Inhibitor p16.
Connection Strength
0.016
-
Phase II trial of adjuvant gemcitabine plus cisplatin-based chemotherapy in patients with locally advanced bladder cancer. Clin Genitourin Cancer. 2006 Sep; 5(2):150-4.
Score: 0.016
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.